Haughney John, Cotton Philip, Rosen Jan-Paul, Rosen Jan-Paul, Morrison Ken, Price David
Department of General Practice and Primary Care, University of Aberdeen, Aberdeen, Scotland, UK.
Prim Care Respir J. 2007 Apr;16(2):89-92. doi: 10.3132/pcrj.2007.00014.
To ascertain if the Patient Enablement Instrument (PEI) could be adapted for use in asthma management, and to use it to evaluate "enablement" in patients with asthma randomised to either a fixed or adjustable medication dosing regime.
The original Patient Enablement Instrument was modified by making a minor change to the opening statement. 228 adults with asthma from 72 UK general practices were recruited to the study. The internal and external consistencies of the modified PEI were assessed. Individual scores were compared across treatment groups.
The modified PEI had high internal consistency. There was a significant correlation between modified PEI total score and change in Mini Asthma Quality of Life Questionnaire. A significantly greater proportion of patients using adjustable medication dosing had a clinically relevant treatment benefit.
The Patient Enablement Instrument can be used to measure "enablement" in asthma.
确定患者赋能工具（PEI）是否可适用于哮喘管理，并使用该工具评估随机接受固定或可调药物给药方案的哮喘患者的“赋能”情况。
通过对开场白进行细微修改，对原始的患者赋能工具进行了调整。从英国72家全科诊所招募了228名成年哮喘患者参与该研究。评估了修改后的PEI的内部和外部一致性。比较了各治疗组的个体得分。
修改后的PEI具有较高的内部一致性。修改后的PEI总分与小型哮喘生活质量问卷的变化之间存在显著相关性。使用可调药物给药的患者中，有临床相关治疗益处的比例显著更高。
患者赋能工具可用于衡量哮喘患者的“赋能”情况。
